Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Silke Marhenke"'
Autor:
Laura Elisa Buitrago-Molina, Silke Marhenke, Diana Becker, Robert Geffers, Timo Itzel, Andreas Teufel, Hartmut Jaeschke, André Lechel, Kristian Unger, Jovana Markovic, Amar Deep Sharma, Jens U. Marquardt, Michael Saborowski, Anna Saborowski, Arndt Vogel
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 11, Iss 5, Pp 1387-1404 (2021)
Background & Aims: A coordinated stress and regenerative response is important after hepatocyte damage. Here, we investigate the phenotypes that result from genetic abrogation of individual components of the checkpoint kinase 2/transformation-related
Externí odkaz:
https://doaj.org/article/ea76095698c54cfd9a029459addf3d3a
Autor:
Fabian Richter, Sarah K. Williams, Katharina John, Carina Huber, Camille Vaslin, Henri Zanker, Richard Fairless, Kira Pichi, Silke Marhenke, Arndt Vogel, Marie-Ann Dhaen, Stefanie Herrmann, Andreas Herrmann, Klaus Pfizenmaier, Heike Bantel, Ricarda Diem, Roland E. Kontermann, Roman Fischer
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Therapeutics that block tumor necrosis factor (TNF), and thus activation of TNF receptor 1 (TNFR1) and TNFR2, are clinically used to treat inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease and psoriasis. However, TNFR1 an
Externí odkaz:
https://doaj.org/article/1a907a62ef2147babfb0eca1aa339f4b
Autor:
Jens U. Marquardt, Michael Saborowski, Silke Marhenke, Ralph M. Wirtz, Andreas Pich, Arndt Vogel, Anna Saborowski, Gajanan Kendre, Norman Woller, Tanja Poth, D Becker, Karthikeyan Murugesan, Tanja Reineke-Plaaß, Georgina Lorz, Florian Kühnel
Publikováno v:
Hepatology. 74:1357-1370
Background and aims Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer and a highly lethal malignancy. Chemotherapeutic options are limited, but a considerable subset of patients harbors genetic lesions for which tar
Autor:
Stephan, Buch, Hamish, Innes, Philipp Ludwig, Lutz, Hans Dieter, Nischalke, Jens U, Marquardt, Janett, Fischer, Karl Heinz, Weiss, Jonas, Rosendahl, Astrid, Marot, Marcin, Krawczyk, Markus, Casper, Frank, Lammert, Florian, Eyer, Arndt, Vogel, Silke, Marhenke, Johann, von Felden, Rohini, Sharma, Stephen Rahul, Atkinson, Andrew, McQuillin, Jacob, Nattermann, Clemens, Schafmayer, Andre, Franke, Christian, Strassburg, Marcella, Rietschel, Heidi, Altmann, Stefan, Sulk, Veera Raghavan, Thangapandi, Mario, Brosch, Carolin, Lackner, Rudolf E, Stauber, Ali, Canbay, Alexander, Link, Thomas, Reiberger, Mattias, Mandorfer, Georg, Semmler, Bernhard, Scheiner, Christian, Datz, Stefano, Romeo, Stefano, Ginanni Corradini, William Lucien, Irving, Joanne R, Morling, Indra Neil, Guha, Eleanor, Barnes, M Azim, Ansari, Jocelyn, Quistrebert, Luca, Valenti, Sascha A, Müller, Marsha Yvonne, Morgan, Jean-François, Dufour, Jonel, Trebicka, Thomas, Berg, Pierre, Deltenre, Sebastian, Mueller, Jochen, Hampe, Felix, Stickel
Publikováno v:
Gut.
Hepatocellular carcinoma (HCC) often develops in patients with alcohol-related cirrhosis at an annual risk of up to 2.5%. Some host genetic risk factors have been identified but do not account for the majority of the variance in occurrence. This stud
Autor:
Nora Schweitzer, Martha M. Kirstein, Thomas Rodt, Silke Marhenke, Arndt Vogel, Matthias Pinter, Bernhard Scheiner, Lena Schulte, Jan B. Hinrichs, Arndt Weinmann, Sandra Koch, Michael P. Manns, Philipp Ivanyi, Torsten Voigtländer
Publikováno v:
Liver International. 39:714-726
BACKGROUND Hepatocellular carcinoma (HCC) is one of the most lethal cancers. Nutrition- and life style-associated risk factors are increasingly prevalent. Metformin, the mainstay of type 2 diabetes mellitus (T2DM)-treatment, reduces the risk of hepat
Autor:
Stephan Buch, Hamish Innes, Philipp Lutz, Hans Dieter Nischalke, Jacob Nattermann, Jens U. Marquardt, Janett Fischer, Karl Heinz Weiss, Jonas Rosendahl, Astrid Marot, Marcin Krawczyk, Markus Casper, Frank Lammert, Florian Eyer, Arndt Vogel, Silke Marhenke, Johann von Felden, Rohini Sharma, Stephen Atkinson, Andrew McQuillin, Clemens Schafmayer, Christian Strassburg, Heidi Altmann, Stefan Sulk, Veera Raghavan Thangapandi, Mario Brosch, Carolin Lackner, Rudolf E. Stauber, Ali Canbay, Alexander Link, Thomas Reiberger, Mattias Mandorfer, Georg Semmler, Bernhard Scheiner, Christian Datz, Stefano Romeo, Stefano Ginanni Corradini, Luca Valenti, Sascha Müller, Marsha Morgan, Jean-Francois Dufour, Jonel Trebicka, Thomas Berg, Pierre Deltenre, Sebastian Mueller, Jochen Hampe, Felix Stickel
Publikováno v:
Journal of Hepatology. 77:S11
Publikováno v:
Journal of Hepatology. 77:S666
Autor:
Roland E. Kontermann, Timo Itzel, F Wandrer, Olaf Maier, Klaus Pfizenmaier, Thomas Longerich, Klaus Schulze-Osthoff, Michael P. Manns, Stephanie Liebig, Andreas Teufel, Roman Fischer, Katharina John, Silke Marhenke, Heike Bantel, Arndt Vogel
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 11, Iss 3, Pp 1-9 (2020)
Cell Death and Disease, Vol 11, Iss 3, Pp 1-9 (2020)
Non-alcoholic fatty liver disease (NAFLD) shows an increasing prevalence and is associated with the development of liver fibrosis and cirrhosis as the major risk factors of liver-related mortality in this disease. The therapeutic possibilities are li
Autor:
Martha M. Kirstein, Frauke Metzler, Silke Marhenke, Ingmar Mederacke, Arndt Vogel, Young-Seon Mederacke, Michael P. Manns, Anika Großhennig
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 51(11)
Background: Fibrosis progression in autoimmune hepatitis can be attenuated by immunosuppressive treatment; however, some patients progress despite therapy. Single nucleotide polymorphisms (SNPs) such as PNPLA3-rs738409, TM6SF2-rs58542926 and MBOAT7-r
Autor:
Dorothee Römermann, Silke Marhenke, Arndt Vogel, Matthias Hardtke-Wolenski, Thomas Longerich, Nadiea Ansari, Alina Michael, Adriana Rita Schultz‐Moreira, Michael P. Manns, Laura Elisa Buitrago-Molina, Heiner Wedemeyer
Background and aims Autophagy is a critical process in cell survival and the maintenance of homeostasis. However, the implementation of therapeutic approaches based on autophagy mechanisms after liver damage is still challenging. Methods We used a he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20fa176302350e2c0a10f167626c35f2
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85082055504
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85082055504